precess medical derivatives
US H-1B Labor Condition Application activity for precess medical derivatives. Filed 76 disclosures between FY2011 and FY2026 from worksites with a NJ headquarters indicator.
H-1B outcome breakdown
Share of precess medical derivatives’s LCAs by DOL case status, all fiscal years. Use the year filter above for a single-year breakdown.
| Outcome | Share |
|---|---|
| Certified | 98.7% |
| Denied | 1.3% |
Top occupations sponsored
SOC codes filed most by precess medical derivatives across all fiscal years. Click any row to open the national salary guide.
| # | SOC | Title | Filings |
|---|---|---|---|
| 1 | 19-2012 | Physicists | 71 |
| 2 | 29-2036 | Medical Dosimetrists | 2 |
| 3 | 15-1252 | Software Developers | 1 |
| 4 | 11-3071 | Transportation, Storage, and Distribution Managers | 1 |
H-1B filings by fiscal year
Year-over-year H-1B filing volume — a hiring-demand signal, not headcount.
| Year | Filings |
|---|---|
| FY2011 | 2 |
| FY2015 | 1 |
| FY2016 | 5 |
| FY2018 | 3 |
| FY2019 | 1 |
| FY2023 | 1 |
| FY2024 | 12 |
| FY2025 | 27 |
| FY2026 | 24 |
| Period | Value |
|---|---|
| FY2011 | 2 |
| FY2015 | 1 |
| FY2016 | 5 |
| FY2018 | 3 |
| FY2019 | 1 |
| FY2023 | 1 |
| FY2024 | 12 |
| FY2025 | 27 |
| FY2026 | 24 |
This employer filed at least one WARN Act notice in the last 24 months — a state-mandated advance announcement of a planned mass layoff or closure. A notice is an announcement, not a completed layoff, and it is not evidence of any link between the employer’s H-1B filings and its workforce plans.